These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 9816158)
1. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer. Brenner AJ; Paladugu A; Wang H; Olopade OI; Dreyling MH; Aldaz CM Clin Cancer Res; 1996 Dec; 2(12):1993-8. PubMed ID: 9816158 [TBL] [Abstract][Full Text] [Related]
2. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Kourea HP; Orlow I; Scheithauer BW; Cordon-Cardo C; Woodruff JM Am J Pathol; 1999 Dec; 155(6):1855-60. PubMed ID: 10595915 [TBL] [Abstract][Full Text] [Related]
3. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Bardeesy N; Aguirre AJ; Chu GC; Cheng KH; Lopez LV; Hezel AF; Feng B; Brennan C; Weissleder R; Mahmood U; Hanahan D; Redston MS; Chin L; Depinho RA Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5947-52. PubMed ID: 16585505 [TBL] [Abstract][Full Text] [Related]
4. p16(INK4a) -mediated suppression of telomerase in normal and malignant human breast cells. Bazarov AV; Van Sluis M; Hines WC; Bassett E; Beliveau A; Campeau E; Mukhopadhyay R; Lee WJ; Melodyev S; Zaslavsky Y; Lee L; Rodier F; Chicas A; Lowe SW; Benhattar J; Ren B; Campisi J; Yaswen P Aging Cell; 2010 Oct; 9(5):736-46. PubMed ID: 20569236 [TBL] [Abstract][Full Text] [Related]
5. TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background. Guijarro MV; Nawab A; Dib P; Burkett S; Luo X; Feely M; Nasri E; Seifert RP; Kaye FJ; Zajac-Kaye M Oncogene; 2023 Jun; 42(23):1926-1939. PubMed ID: 37106126 [TBL] [Abstract][Full Text] [Related]
6. Expression, deletion [was deleton] and mutation of p16 gene in human gastric cancer. He XS; Su Q; Chen ZC; He XT; Long ZF; Ling H; Zhang LR World J Gastroenterol; 2001 Aug; 7(4):515-21. PubMed ID: 11819820 [TBL] [Abstract][Full Text] [Related]
7. Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Li J; Poi MJ; Tsai MD Biochemistry; 2011 Jun; 50(25):5566-82. PubMed ID: 21619050 [TBL] [Abstract][Full Text] [Related]
9. Characterizing the amyloid core region of the tumor suppressor protein p16 Heath SG; Naughton JD; Magon NJ; Gray SG; Smith BR; Morris VK; Göbl C J Biol Chem; 2024 Aug; 300(8):107590. PubMed ID: 39032649 [TBL] [Abstract][Full Text] [Related]
10. Derivation of human primary prostate epithelial cell lines by differentially targeting the Wasserman JS; Fowle H; Hashmi R; Atar D; Patel K; Yarmahmoodi A; Macfarlane AW; Tan Y; Cukierman E; Gligorijevic B; Karami A; Whelan KA; Campbell KS; Graña X Res Sq; 2024 May; ():. PubMed ID: 38766032 [TBL] [Abstract][Full Text] [Related]
11. RNA splicing variants of the novel long non-coding RNA, CyKILR, possess divergent biological functions in non-small cell lung cancer. Xie X; Macknight HP; Lu AL; Chalfant CE bioRxiv; 2024 Jul; ():. PubMed ID: 39026815 [TBL] [Abstract][Full Text] [Related]
12. Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype. Zając A; Król SK; Rutkowski P; Czarnecka AM Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804155 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic Silencing of Singh SP; Tewari M; Singh AK; Mishra RR; Shukla HS Indian J Surg Oncol; 2023 Dec; 14(4):822-828. PubMed ID: 38187858 [TBL] [Abstract][Full Text] [Related]
14. Centrosome aberrations in human mammary epithelial cells driven by cooperative interactions between p16INK4a deficiency and telomere-dependent genotoxic stress. Domínguez D; Feijoo P; Bernal A; Ercilla A; Agell N; Genescà A; Tusell L Oncotarget; 2015 Sep; 6(29):28238-56. PubMed ID: 26318587 [TBL] [Abstract][Full Text] [Related]
15. Methylation and Immunoexpression of p16(INK4a) Tumor Suppressor Gene in Primary Breast Cancer Tissue and Their Quantitative p16(INK4a) Hypermethylation in Plasma by Real-Time PCR. Lee JJ; Ko E; Cho J; Park HY; Lee JE; Nam SJ; Kim DH; Cho EY Korean J Pathol; 2012 Dec; 46(6):554-61. PubMed ID: 23323106 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Breast Tumor Cell Growth by Ectopic Expression of p16/INK4A Via Combined Effects of Cell Cycle Arrest, Senescence and Apoptotic Induction, and Angiogenesis Inhibition. Lu Y; Zhang X; Zhang J J Cancer; 2012; 3():333-44. PubMed ID: 22866168 [TBL] [Abstract][Full Text] [Related]
17. Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation. Kamalakaran S; Kendall J; Zhao X; Tang C; Khan S; Ravi K; Auletta T; Riggs M; Wang Y; Helland A; Naume B; Dimitrova N; Børresen-Dale AL; Hicks J; Lucito R Nucleic Acids Res; 2009 Jul; 37(12):e89. PubMed ID: 19474344 [TBL] [Abstract][Full Text] [Related]
18. Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer. Vallian S; Sedaghat M; Nassiri I; Frazmand A J Cancer Res Clin Oncol; 2009 Aug; 135(8):991-6. PubMed ID: 19125298 [TBL] [Abstract][Full Text] [Related]
19. Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis. Zhang J; Lu A; Beech D; Jiang B; Lu Y Cancer Ther; 2007; 5():273-286. PubMed ID: 18548129 [TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of promoter hypermethylation during breast cancer development. Lehmann U; Länger F; Feist H; Glöckner S; Hasemeier B; Kreipe H Am J Pathol; 2002 Feb; 160(2):605-12. PubMed ID: 11839581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]